Figure 1From: A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorderADHDRS-IV-Parent:Inv mean total scores (SE) across treatment weeks. *P ≤ .05, atomoxetine and placebo (excluding early responders) vs atomoxetine and methylphenidate.Back to article page